ArticleVaccines2023

Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits.

Selina Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.